Christophe Chassagnole
CSO, XTalos Ltd
Dr Christophe Chassagnole, is the Co-Founder and Chief Scientific Officer of XTalos. Christophe brings extensive expertise in cancer research and biotechnology, has strong operational experience having led over 100 oncology projects for clients ranging from start-ups to Top 10 Pharmaceuticals. He has Board-level experience in a listed biotech company from pre-IPO through to successive funding rounds, where he also helped secure several grants. He holds a PhD in Biochemistry from the Université of Bordeaux.
Events Christophe Chassagnole has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026